You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (58)

Journals (0)

1-10 of 58 results for EGFR-mutant NSCLC

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: M6A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC

Open access

Research article

First published 2025-05

M6A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC

Yaofeng Zhi, Silin Liu, Xuefei Chang [...]

Cancer Control

Select article: Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis

Open access

Research article

First published 2026

Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis

Zexian Wang, Yaru Guo, Xiaohan Qin [...]

Clinical Medicine Insights: Oncology

Select article: Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

Retricted access

Letter

First published 2022-4

Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

Jessica Freydman, Lynnette Henshaw, Jasmine V. Patel [...]

Annals of Pharmacotherapy

Select article: Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

Open access

Research article

First published 2025

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

Cam Phuong Pham, Hung Kien Do, Anh Tu Do [...]

Therapeutic Advances in Medical Oncology

Select article: RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report

Open access

Research article

First published 2019

RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report

Fei Gao, Xiuyan Wu, Jie Wu [...]

European Journal of Inflammation

Select article: Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Free access

Research article

First published 2011-8

Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer

B Jiang, F Liu, L Yang [...]

Journal of International Medical Research

Select article: Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench

Open access

Review article

First published 2020

Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench

Rui Jin, Jing Zhao, Lexin Xia [...]

Therapeutic Advances in Medical Oncology

Select article: Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer

Open access

Review article

First published 2023

Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer

Yang-Si Li, Guang-Ling Jie, Yi-Long Wu

Therapeutic Advances in Medical Oncology

Select article: A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care

Retricted access

Review article

First published 2020-9

A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care

Osama M Al-Quteimat, Amer M Amer

Journal of Oncology Pharmacy Practice

Select article: Gefitinib-Sensitive EGFR Lacking Residues 746–750 Exhibits Hypophosphorylation at Tyrosine Residue 1045,Hypoubiquitination,And Impaired Endocytosis

Retricted access

Research article

First published 2007-03

Gefitinib-Sensitive EGFR Lacking Residues 746–750 Exhibits Hypophosphorylation at Tyrosine Residue 1045,Hypoubiquitination,And Impaired Endocytosis

Mitsugi Furukawa, Izumi Nagatomo, Toru Kumagai [...]

DNA and Cell Biology

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access